We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Ad image
Business

Immunovia is hosting a webcast offering an opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test.

MONews
MONews
2 Min Read
Immunovia is hosting a webcast offering an opportunity to learn more about the positive clinical validation of its next-generation pancreatic cancer test.

Lund, Sweden, December 16, 2024 /PRNewswire/ — immunity A pancreatic cancer diagnostic company (IMMNOV: Nasdaq Stockholm) announced positive results from clinical validation of a next-generation pancreatic cancer screening method. December 9, 2024. As a follow up, immunity We will be hosting a webcast. Tuesday, December 17th to 3:00 PM (CET).

Jeff BorcherdingCEO, Norma Alonzo PalmaPhD, Clinical Vice President and medical treatment (TASE:) work and Lisa Ford (NYSE:)PhD, the lab director, will present additional details about the findings and implications of the study. doctor. Amy LucasDepartment of Gastroenterology and Hepatology Mount Sinai and professor Medicine Icahn School of MedicineWe will be joining the webcast to share our perspectives on our findings. The webcast will be in English and will provide attendees with the opportunity to ask questions. Welcome to membership. See below for more details.

Webcast link: https://link.edgepilot.com/s/e8dd2ee9/T5WEGMPm6EqzxajKwPwQbw?u=https://creo-live.creomediamanager.com/dd81645b-30e0-45e1-af83-75a059fcba71

A recording of the presentation is available at: immunity Website.

For more information, please contact:
Karin Almqvist Rivendal
chief financial officer
karin.almqvist.liwendahl@immunovia.com

immunity In short

immunity AB It is a diagnostic company whose mission is to increase the survival rate of pancreatic cancer patients through early detection. immunity is focused on the development and commercialization of simple blood-based tests that detect proteins and antibodies indicative of the development of pancreatic cancer in high-risk individuals.

immunity We collaborate and engage with health care providers, leading experts, and patient advocacy groups to provide testing to individuals at high risk for pancreatic cancer.

USA The pancreatic cancer diagnosis market is the world’s largest. The company estimates as follows: USA1.8 million individuals are at high risk for pancreatic cancer and would benefit from annual surveillance testing.

immunity The stock (IMMNOV) is listed on Nasdaq Stockholm. For more information, visit www.immunovia.com.

This information is provided by Cision http://news.cision.com.

https://news.cision.com/immunovia-ab/r/immunovia-to-host-a-webcast-with-the-opportunity-to-learn-more-about-the-positive-clinical-validatio,c4082507

You can download the following files:

https://mb.cision.com/Main/13121/4082507/3173482.pdf

Press release (PDF)

TAGGED:
Share This Article
Previous Article We’ve come a long way with RPA. How AI Agents Are Transforming Automation We’ve come a long way with RPA. How AI Agents Are Transforming Automation
Next Article Ferns may evolve backwards, challenging common assumptions about life. Ferns may evolve backwards, challenging common assumptions about life.